Newsletters
The Capitalist Newsletter – May 2, 2017
INTRODUCING GUY COHEN; YOUR NEW TECHNICAL ADVISOR — COURTESY OF THE CAPITALIST |
|
Winners & Losers – MEDICAL TRANSCRIPTION BILLING, Corp. (MTBC) Rockets UP (76.47%) After Announcing it Successfully Developed Health Information Exchange Interfaces for Interoperability Between its Platforms and Leading Hospitals – Aeterna Zentaris, Inc. (AEZS) Tumbles DOWN (59.70%) After Announcing Phase 3 Clinical Study Did Not Achieve its Primary Endpoint
Most Talked About Intra-Cellular Therapies, Inc. (ITCI) Considered a Majority Strong Buy After Falling DOWN (24.10%) Following News that the FDA Confirmed the Results of a Study of Company’s Schizophrenia Drug Don’t Prevent ITCI from Filing New Drug Application, but FDA Raised Questions About Toxicology Studies of the Drug
The TIP Sheets – Monday, May 1st – MEDICAL TRANSCRIPTION BILLING, Corp. (MTBC) Rockets UP (76.47%) After Announcing it Successfully Developed Health Information Exchange Interfaces for Interoperability Between its Platforms and Leading Hospitals. Expect Shares to Continue UP
Unusual Volume
Ocwen Financial Corp (OCN) Rises UP (35.37%) on 36m Shares Traded After Company Unloads $425m in Assets. However, the Company is Still Being Sued by the State of Massachusetts (and Others) for Shady Lending and Mortgage Practices. Expect Shares to Come Back DOWN |
